Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays

In addition to dermatological complications, acne can affect the quality of life of individuals in numerous ways, such as employment, social habits and body dissatisfaction. According to our expertise, caprylic acid and propanediol would not have a direct action on <i>Cutibacterium acnes</i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lilian Mussi, André Rolim Baby, Flavio Bueno Camargo Junior, Giovana Padovani, Bianca da Silva Sufi, Wagner Vidal Magalhães
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/18ac208429184b9b89ced7395dc33c53
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:18ac208429184b9b89ced7395dc33c53
record_format dspace
spelling oai:doaj.org-article:18ac208429184b9b89ced7395dc33c532021-11-11T18:39:08ZPropanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays10.3390/molecules262167041420-3049https://doaj.org/article/18ac208429184b9b89ced7395dc33c532021-11-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/21/6704https://doaj.org/toc/1420-3049In addition to dermatological complications, acne can affect the quality of life of individuals in numerous ways, such as employment, social habits and body dissatisfaction. According to our expertise, caprylic acid and propanediol would not have a direct action on <i>Cutibacterium acnes</i>. Despite this, we investigated the existence of a synergistic effect among xylitol, caprylic acid and propanediol as a mixture of compounds representing a single topical active ingredient that could benefit the treatment against acne. In vitro and in vivo assays were performed to challenge and to prove the efficacy of propanediol, xylitol and caprylic acid (PXCA) against acne. PXCA had its MIC challenged against <i>C. acnes</i> (formerly <i>Propionibacterium acnes</i>) and <i>Staphylococcus aureus</i>, resulting in concentrations of 0.125% and 0.25%, respectively, and it also developed antimicrobial activity against <i>C. acnes</i> (time-kill test). PXCA was able to reduce the 5-alpha reductase expression in 24% (<i>p</i> < 0.01) in comparison with the testosterone group. By the end of 28 days of treatment, the compound reduced the skin oiliness, porphyrin amount and the quantity of inflammatory lesions in participants. According to the dermatologist evaluation, PXCA improved the skin’s general appearance, acne presence and size.Lilian MussiAndré Rolim BabyFlavio Bueno Camargo JuniorGiovana PadovaniBianca da Silva SufiWagner Vidal MagalhãesMDPI AGarticleacnexylitolcaprylic acidpropanediolporphyrin5-alpha reductaseOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6704, p 6704 (2021)
institution DOAJ
collection DOAJ
language EN
topic acne
xylitol
caprylic acid
propanediol
porphyrin
5-alpha reductase
Organic chemistry
QD241-441
spellingShingle acne
xylitol
caprylic acid
propanediol
porphyrin
5-alpha reductase
Organic chemistry
QD241-441
Lilian Mussi
André Rolim Baby
Flavio Bueno Camargo Junior
Giovana Padovani
Bianca da Silva Sufi
Wagner Vidal Magalhães
Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays
description In addition to dermatological complications, acne can affect the quality of life of individuals in numerous ways, such as employment, social habits and body dissatisfaction. According to our expertise, caprylic acid and propanediol would not have a direct action on <i>Cutibacterium acnes</i>. Despite this, we investigated the existence of a synergistic effect among xylitol, caprylic acid and propanediol as a mixture of compounds representing a single topical active ingredient that could benefit the treatment against acne. In vitro and in vivo assays were performed to challenge and to prove the efficacy of propanediol, xylitol and caprylic acid (PXCA) against acne. PXCA had its MIC challenged against <i>C. acnes</i> (formerly <i>Propionibacterium acnes</i>) and <i>Staphylococcus aureus</i>, resulting in concentrations of 0.125% and 0.25%, respectively, and it also developed antimicrobial activity against <i>C. acnes</i> (time-kill test). PXCA was able to reduce the 5-alpha reductase expression in 24% (<i>p</i> < 0.01) in comparison with the testosterone group. By the end of 28 days of treatment, the compound reduced the skin oiliness, porphyrin amount and the quantity of inflammatory lesions in participants. According to the dermatologist evaluation, PXCA improved the skin’s general appearance, acne presence and size.
format article
author Lilian Mussi
André Rolim Baby
Flavio Bueno Camargo Junior
Giovana Padovani
Bianca da Silva Sufi
Wagner Vidal Magalhães
author_facet Lilian Mussi
André Rolim Baby
Flavio Bueno Camargo Junior
Giovana Padovani
Bianca da Silva Sufi
Wagner Vidal Magalhães
author_sort Lilian Mussi
title Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays
title_short Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays
title_full Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays
title_fullStr Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays
title_full_unstemmed Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays
title_sort propanediol (and) caprylic acid (and) xylitol as a new single topical active ingredient against acne: in vitro and in vivo efficacy assays
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/18ac208429184b9b89ced7395dc33c53
work_keys_str_mv AT lilianmussi propanediolandcaprylicacidandxylitolasanewsingletopicalactiveingredientagainstacneinvitroandinvivoefficacyassays
AT andrerolimbaby propanediolandcaprylicacidandxylitolasanewsingletopicalactiveingredientagainstacneinvitroandinvivoefficacyassays
AT flaviobuenocamargojunior propanediolandcaprylicacidandxylitolasanewsingletopicalactiveingredientagainstacneinvitroandinvivoefficacyassays
AT giovanapadovani propanediolandcaprylicacidandxylitolasanewsingletopicalactiveingredientagainstacneinvitroandinvivoefficacyassays
AT biancadasilvasufi propanediolandcaprylicacidandxylitolasanewsingletopicalactiveingredientagainstacneinvitroandinvivoefficacyassays
AT wagnervidalmagalhaes propanediolandcaprylicacidandxylitolasanewsingletopicalactiveingredientagainstacneinvitroandinvivoefficacyassays
_version_ 1718431748720689152